Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 8.78653995 |
2 | positive thymic T cell selection (GO:0045059) | 7.96292244 |
3 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.94503743 |
4 | positive T cell selection (GO:0043368) | 7.63276558 |
5 | interferon-gamma production (GO:0032609) | 7.44710746 |
6 | negative T cell selection (GO:0043383) | 7.13213813 |
7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.02797720 |
8 | regulation of gamma-delta T cell activation (GO:0046643) | 6.95306438 |
9 | negative thymic T cell selection (GO:0045060) | 6.83067788 |
10 | T cell migration (GO:0072678) | 6.55806842 |
11 | thymic T cell selection (GO:0045061) | 6.55092356 |
12 | response to interleukin-15 (GO:0070672) | 6.16273414 |
13 | leukocyte aggregation (GO:0070486) | 6.03915861 |
14 | T cell selection (GO:0045058) | 5.78157213 |
15 | T cell receptor signaling pathway (GO:0050852) | 5.64374913 |
16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.43737239 |
17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.43737239 |
18 | glycosphingolipid catabolic process (GO:0046479) | 5.16955295 |
19 | cellular response to interleukin-15 (GO:0071350) | 5.10566248 |
20 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.04111619 |
21 | regulation of mononuclear cell migration (GO:0071675) | 4.92915825 |
22 | activated T cell proliferation (GO:0050798) | 4.88127269 |
23 | virion attachment to host cell (GO:0019062) | 4.70607880 |
24 | adhesion of symbiont to host cell (GO:0044650) | 4.70607880 |
25 | glycolipid catabolic process (GO:0019377) | 4.67643067 |
26 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.66818258 |
27 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.60267955 |
28 | oligosaccharide catabolic process (GO:0009313) | 4.57287916 |
29 | negative regulation of interleukin-12 production (GO:0032695) | 4.48296462 |
30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.43353859 |
31 | T cell costimulation (GO:0031295) | 4.39956510 |
32 | lymphocyte costimulation (GO:0031294) | 4.32396019 |
33 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.29930160 |
34 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.24323090 |
35 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.19090767 |
36 | adhesion of symbiont to host (GO:0044406) | 4.10683632 |
37 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.09258069 |
38 | ceramide catabolic process (GO:0046514) | 4.07006560 |
39 | regulation of vitamin metabolic process (GO:0030656) | 4.05046150 |
40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.00668339 |
41 | amino sugar catabolic process (GO:0046348) | 3.99907317 |
42 | regulation of regulatory T cell differentiation (GO:0045589) | 3.97402519 |
43 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.93358489 |
44 | macrophage activation involved in immune response (GO:0002281) | 3.93356732 |
45 | response to peptidoglycan (GO:0032494) | 3.92259155 |
46 | heterotypic cell-cell adhesion (GO:0034113) | 3.91491489 |
47 | leukocyte cell-cell adhesion (GO:0007159) | 3.91385804 |
48 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.91083715 |
49 | mast cell degranulation (GO:0043303) | 3.85121604 |
50 | mast cell activation involved in immune response (GO:0002279) | 3.85121604 |
51 | neutrophil activation involved in immune response (GO:0002283) | 3.83511073 |
52 | angiotensin maturation (GO:0002003) | 3.82964177 |
53 | positive regulation of isotype switching (GO:0045830) | 3.76518050 |
54 | natural killer cell differentiation (GO:0001779) | 3.73921243 |
55 | T-helper 1 type immune response (GO:0042088) | 3.73169215 |
56 | response to acidic pH (GO:0010447) | 3.73145373 |
57 | regulation of podosome assembly (GO:0071801) | 3.70233688 |
58 | T cell differentiation (GO:0030217) | 3.69582002 |
59 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.69422439 |
60 | membrane lipid catabolic process (GO:0046466) | 3.69207175 |
61 | positive regulation of histone deacetylation (GO:0031065) | 3.66532399 |
62 | mast cell activation (GO:0045576) | 3.66071566 |
63 | positive regulation of interleukin-2 production (GO:0032743) | 3.63631028 |
64 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.62257030 |
65 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.62207946 |
66 | sphingolipid catabolic process (GO:0030149) | 3.60029697 |
67 | immunoglobulin mediated immune response (GO:0016064) | 3.59826443 |
68 | regulation of T cell tolerance induction (GO:0002664) | 3.56377457 |
69 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.55159558 |
70 | viral transcription (GO:0019083) | 3.53627819 |
71 | regulation of chemokine biosynthetic process (GO:0045073) | 3.52209953 |
72 | positive regulation of heat generation (GO:0031652) | 3.50353693 |
73 | megakaryocyte development (GO:0035855) | 3.49792919 |
74 | alpha-beta T cell activation (GO:0046631) | 3.49495648 |
75 | regulation of B cell differentiation (GO:0045577) | 3.49372954 |
76 | NIK/NF-kappaB signaling (GO:0038061) | 3.46663513 |
77 | V(D)J recombination (GO:0033151) | 3.43610116 |
78 | eosinophil chemotaxis (GO:0048245) | 3.39729209 |
79 | ribosomal small subunit assembly (GO:0000028) | 3.37906453 |
80 | lymphocyte migration (GO:0072676) | 3.37331812 |
81 | cellular response to interleukin-4 (GO:0071353) | 3.36732121 |
82 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.34075673 |
83 | positive regulation of Rap GTPase activity (GO:0032854) | 3.33432932 |
84 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.33109054 |
85 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.32089768 |
86 | regulation of fever generation (GO:0031620) | 3.31204339 |
87 | cell wall macromolecule catabolic process (GO:0016998) | 3.31153454 |
88 | N-acetylneuraminate metabolic process (GO:0006054) | 3.28503133 |
89 | translational termination (GO:0006415) | 3.27880903 |
90 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.27848350 |
91 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.27713076 |
92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.24627074 |
93 | T cell activation (GO:0042110) | 3.22827893 |
94 | signal complex assembly (GO:0007172) | 3.21106548 |
95 | regulation of macrophage chemotaxis (GO:0010758) | 3.20631807 |
96 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.20102820 |
97 | Peyers patch development (GO:0048541) | 3.18801039 |
98 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.18801039 |
99 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.17693889 |
100 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.17693889 |
101 | sequestering of actin monomers (GO:0042989) | 3.17626997 |
102 | T cell homeostasis (GO:0043029) | 3.17335473 |
103 | regulation of isotype switching (GO:0045191) | 3.17059301 |
104 | monocyte chemotaxis (GO:0002548) | 3.16924759 |
105 | peptide catabolic process (GO:0043171) | 3.16203441 |
106 | barbed-end actin filament capping (GO:0051016) | 3.16161826 |
107 | leukocyte tethering or rolling (GO:0050901) | 3.15815544 |
108 | alpha-beta T cell differentiation (GO:0046632) | 3.15803374 |
109 | regulation of interferon-alpha production (GO:0032647) | 3.14878871 |
110 | response to interleukin-4 (GO:0070670) | 3.14560943 |
111 | low-density lipoprotein particle clearance (GO:0034383) | 3.12235224 |
112 | regulation of chronic inflammatory response (GO:0002676) | 3.11538397 |
113 | negative regulation of T cell mediated immunity (GO:0002710) | 3.11293341 |
114 | B cell receptor signaling pathway (GO:0050853) | 3.11132417 |
115 | positive regulation of leukocyte degranulation (GO:0043302) | 3.10428075 |
116 | myeloid dendritic cell differentiation (GO:0043011) | 3.10268436 |
117 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.10208943 |
118 | natural killer cell activation (GO:0030101) | 3.08931677 |
119 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.08298973 |
120 | cellular response to arsenic-containing substance (GO:0071243) | 3.05801673 |
121 | platelet formation (GO:0030220) | 3.03577280 |
122 | response to thyroid hormone (GO:0097066) | 3.01609967 |
123 | positive regulation of DNA recombination (GO:0045911) | 3.00816853 |
124 | adaptation of signaling pathway (GO:0023058) | 3.00332270 |
125 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.99785961 |
126 | T cell proliferation (GO:0042098) | 2.99737320 |
127 | eosinophil migration (GO:0072677) | 2.99094647 |
128 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98636008 |
129 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.98427461 |
130 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.97267613 |
131 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.96860415 |
132 | positive regulation of T cell differentiation (GO:0045582) | 2.95447484 |
133 | regulation of response to interferon-gamma (GO:0060330) | 2.93937476 |
134 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.91285545 |
135 | positive regulation of lamellipodium assembly (GO:0010592) | 2.91245020 |
136 | regulation of mast cell degranulation (GO:0043304) | 2.89861075 |
137 | mature B cell differentiation involved in immune response (GO:0002313) | 2.88441900 |
138 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.87235542 |
139 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.87073234 |
140 | positive regulation of mRNA catabolic process (GO:0061014) | 2.85711781 |
141 | cellular extravasation (GO:0045123) | 2.84421901 |
142 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.84218868 |
143 | regulation of cholesterol storage (GO:0010885) | 2.83960482 |
144 | positive regulation of T cell activation (GO:0050870) | 2.82223612 |
145 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.82204071 |
146 | positive regulation by symbiont of host defense response (GO:0052509) | 2.82202138 |
147 | modulation by symbiont of host defense response (GO:0052031) | 2.82202138 |
148 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.82202138 |
149 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.82202138 |
150 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.82202138 |
151 | modulation by symbiont of host immune response (GO:0052553) | 2.82202138 |
152 | positive regulation of B cell mediated immunity (GO:0002714) | 2.82127221 |
153 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.82127221 |
154 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80835618 |
155 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.80355588 |
156 | negative regulation of phagocytosis (GO:0050765) | 2.80244686 |
157 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.80014596 |
158 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.79958106 |
159 | positive regulation of mast cell degranulation (GO:0043306) | 2.79958106 |
160 | protein localization to endosome (GO:0036010) | 2.79909350 |
161 | DNA unwinding involved in DNA replication (GO:0006268) | 2.79473444 |
162 | positive regulation of protein deacetylation (GO:0090312) | 2.79070050 |
163 | translational elongation (GO:0006414) | 2.78983653 |
164 | regulation of Rap GTPase activity (GO:0032317) | 2.77378459 |
165 | positive regulation of tolerance induction (GO:0002645) | 2.76952279 |
166 | macrophage differentiation (GO:0030225) | 2.76183796 |
167 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.75938489 |
168 | lymphocyte homeostasis (GO:0002260) | 2.75676100 |
169 | positive regulation of humoral immune response (GO:0002922) | 2.75165950 |
170 | cell wall macromolecule metabolic process (GO:0044036) | 2.75091876 |
171 | sexual reproduction (GO:0019953) | 2.74561364 |
172 | regulation of superoxide anion generation (GO:0032928) | 2.71492256 |
173 | cellular response to lipopolysaccharide (GO:0071222) | 2.70578753 |
174 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.70282851 |
175 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70221862 |
176 | granulocyte activation (GO:0036230) | 2.69353159 |
177 | regulation of monocyte chemotaxis (GO:0090025) | 2.69241359 |
178 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.69076539 |
179 | hyaluronan catabolic process (GO:0030214) | 2.68783716 |
180 | pinocytosis (GO:0006907) | 2.68745926 |
181 | adenosine receptor signaling pathway (GO:0001973) | 2.68070756 |
182 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.67590363 |
183 | positive regulation of interleukin-6 production (GO:0032755) | 2.67123325 |
184 | cellular response to type I interferon (GO:0071357) | 2.67017514 |
185 | type I interferon signaling pathway (GO:0060337) | 2.67017514 |
186 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.66006280 |
187 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.65997332 |
188 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.63366243 |
189 | positive regulation of interferon-alpha production (GO:0032727) | 2.62564834 |
190 | germinal center formation (GO:0002467) | 2.62538047 |
191 | response to type I interferon (GO:0034340) | 2.61873798 |
192 | dendritic cell differentiation (GO:0097028) | 2.61724815 |
193 | myeloid dendritic cell activation (GO:0001773) | 2.61546602 |
194 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.61365185 |
195 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.60821152 |
196 | cyclooxygenase pathway (GO:0019371) | 2.60692508 |
197 | cellular response to molecule of bacterial origin (GO:0071219) | 2.59061988 |
198 | regulation of leukocyte degranulation (GO:0043300) | 2.56092402 |
199 | negative regulation of cell killing (GO:0031342) | 10.0040581 |
200 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 10.0040581 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.37960652 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.28498908 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.26383130 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 4.83293298 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.33009224 |
6 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.45538967 |
7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.38827179 |
8 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.36752849 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.31443112 |
10 | UTX_26944678_Chip-Seq_JUKART_Human | 3.25415972 |
11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.18499401 |
12 | MYB_26560356_Chip-Seq_TH2_Human | 3.15072301 |
13 | MAF_26560356_Chip-Seq_TH1_Human | 3.07925061 |
14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.00587154 |
15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.92229374 |
16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.90604640 |
17 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.86020132 |
18 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.82196104 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.81700934 |
20 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.65821271 |
21 | MYB_26560356_Chip-Seq_TH1_Human | 2.65432674 |
22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.61571059 |
23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.61266985 |
24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.55927981 |
25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.47176150 |
26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.43740861 |
27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.24494186 |
28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.22284777 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.20596549 |
30 | MAF_26560356_Chip-Seq_TH2_Human | 2.15262797 |
31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13452726 |
32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12791039 |
33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.12283209 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07925029 |
35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.04145821 |
36 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.02001171 |
37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00524626 |
38 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.98861810 |
39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.95127003 |
40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.92993596 |
41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.89322018 |
42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.87611009 |
43 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.81816751 |
44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.80308550 |
45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.76176098 |
46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75460613 |
47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74735735 |
48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.71700318 |
49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65799848 |
50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64026091 |
51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61312655 |
52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60808102 |
53 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.53910169 |
54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52159622 |
55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.51615480 |
56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51343990 |
57 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51041192 |
58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49824298 |
59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48704533 |
60 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48599442 |
61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48338027 |
62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48068424 |
63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47485892 |
64 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46813560 |
65 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.45516877 |
66 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44759140 |
67 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43230391 |
68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43082961 |
69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.41609909 |
70 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41467550 |
71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.41301658 |
72 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.39406998 |
73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37478880 |
74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36071423 |
75 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.35441207 |
76 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.30894307 |
77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30005920 |
78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28993550 |
79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28942631 |
80 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28493203 |
81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27777445 |
82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26044079 |
83 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25473841 |
84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23574940 |
85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22005651 |
86 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21495554 |
87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19536288 |
88 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18863248 |
89 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18385232 |
90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17244986 |
91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16663808 |
92 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.16286908 |
93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15283706 |
94 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12853593 |
95 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12484266 |
96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12112619 |
97 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10391412 |
98 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10297365 |
99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09899471 |
100 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07211975 |
101 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07066756 |
102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06141599 |
103 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05933711 |
104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05756681 |
105 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05644937 |
106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04120511 |
107 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03769886 |
108 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03228957 |
109 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03100225 |
110 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02964014 |
111 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01646874 |
112 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00968149 |
113 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99654024 |
114 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99475144 |
115 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98739028 |
116 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98382991 |
117 | ATF3_27146783_Chip-Seq_COLON_Human | 0.98318481 |
118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97693365 |
119 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96592628 |
120 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96592628 |
121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96374899 |
122 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96296576 |
123 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95894905 |
124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95766992 |
125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95492149 |
126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94956600 |
127 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94724882 |
128 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94673429 |
129 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.93073916 |
130 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92957797 |
131 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.91091605 |
132 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91017371 |
133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90576036 |
134 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.89853065 |
135 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89682976 |
136 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89590270 |
137 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89013857 |
138 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.88926405 |
139 | P68_20966046_ChIP-Seq_HELA_Human | 0.88656843 |
140 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.87677600 |
141 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87503381 |
142 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87037296 |
143 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86898446 |
144 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.86617113 |
145 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.85174015 |
146 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84888937 |
147 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.84600322 |
148 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83300524 |
149 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.83281768 |
150 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83134770 |
151 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.83025218 |
152 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.82258678 |
153 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81400472 |
154 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80130447 |
155 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.79244348 |
156 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.79169702 |
157 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78990744 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 5.76744149 |
2 | MP0005058_abnormal_lysosome_morphology | 4.97090485 |
3 | MP0000685_abnormal_immune_system | 3.43487361 |
4 | MP0005671_abnormal_response_to | 3.43372336 |
5 | MP0002396_abnormal_hematopoietic_system | 3.34858737 |
6 | MP0002139_abnormal_hepatobiliary_system | 3.26902305 |
7 | MP0000703_abnormal_thymus_morphology | 3.13650808 |
8 | MP0002398_abnormal_bone_marrow | 3.01208674 |
9 | MP0001800_abnormal_humoral_immune | 2.91458945 |
10 | MP0001873_stomach_inflammation | 2.81295317 |
11 | MP0009278_abnormal_bone_marrow | 2.75729604 |
12 | MP0002420_abnormal_adaptive_immunity | 2.74085781 |
13 | MP0001819_abnormal_immune_cell | 2.70285115 |
14 | MP0003300_gastrointestinal_ulcer | 2.63979370 |
15 | MP0002723_abnormal_immune_serum | 2.55172914 |
16 | MP0005451_abnormal_body_composition | 2.54082513 |
17 | MP0002722_abnormal_immune_system | 2.53944180 |
18 | MP0000343_altered_response_to | 2.51685368 |
19 | MP0000716_abnormal_immune_system | 2.49906920 |
20 | MP0003806_abnormal_nucleotide_metabolis | 2.40841324 |
21 | MP0005464_abnormal_platelet_physiology | 2.40817212 |
22 | MP0003866_abnormal_defecation | 2.37555182 |
23 | MP0002452_abnormal_antigen_presenting | 2.28593354 |
24 | MP0005410_abnormal_fertilization | 2.28289735 |
25 | MP0001790_abnormal_immune_system | 2.25188929 |
26 | MP0005387_immune_system_phenotype | 2.25188929 |
27 | MP0009333_abnormal_splenocyte_physiolog | 2.25092690 |
28 | MP0002405_respiratory_system_inflammati | 2.24720532 |
29 | MP0003172_abnormal_lysosome_physiology | 2.23701012 |
30 | MP0003075_altered_response_to | 2.22272076 |
31 | MP0005397_hematopoietic_system_phenotyp | 2.18466048 |
32 | MP0001545_abnormal_hematopoietic_system | 2.18466048 |
33 | MP0000689_abnormal_spleen_morphology | 2.17242474 |
34 | MP0009764_decreased_sensitivity_to | 2.14199014 |
35 | MP0004808_abnormal_hematopoietic_stem | 2.12032378 |
36 | MP0005000_abnormal_immune_tolerance | 2.11375782 |
37 | MP0008961_abnormal_basal_metabolism | 2.09928837 |
38 | MP0002166_altered_tumor_susceptibility | 2.05035967 |
39 | MP0003303_peritoneal_inflammation | 2.03473356 |
40 | MP0002429_abnormal_blood_cell | 2.02975899 |
41 | MP0010352_gastrointestinal_tract_polyps | 2.00210703 |
42 | MP0010155_abnormal_intestine_physiology | 1.96413961 |
43 | MP0005025_abnormal_response_to | 1.94826408 |
44 | MP0004947_skin_inflammation | 1.90365909 |
45 | MP0001835_abnormal_antigen_presentation | 1.84369029 |
46 | MP0003436_decreased_susceptibility_to | 1.76087534 |
47 | MP0002006_tumorigenesis | 1.75965860 |
48 | MP0002419_abnormal_innate_immunity | 1.71775257 |
49 | MP0005167_abnormal_blood-brain_barrier | 1.64137952 |
50 | MP0008004_abnormal_stomach_pH | 1.63693751 |
51 | MP0002933_joint_inflammation | 1.61332022 |
52 | MP0000858_altered_metastatic_potential | 1.61039471 |
53 | MP0003724_increased_susceptibility_to | 1.60308087 |
54 | MP0005166_decreased_susceptibility_to | 1.58561949 |
55 | MP0002998_abnormal_bone_remodeling | 1.57150233 |
56 | MP0004185_abnormal_adipocyte_glucose | 1.53332428 |
57 | MP0000465_gastrointestinal_hemorrhage | 1.52370707 |
58 | MP0001845_abnormal_inflammatory_respons | 1.49934208 |
59 | MP0006054_spinal_hemorrhage | 1.49147555 |
60 | MP0005365_abnormal_bile_salt | 1.46278166 |
61 | MP0005023_abnormal_wound_healing | 1.45238998 |
62 | MP0004510_myositis | 1.38669940 |
63 | MP0008260_abnormal_autophagy | 1.28571673 |
64 | MP0003183_abnormal_peptide_metabolism | 1.28401063 |
65 | MP0004381_abnormal_hair_follicle | 1.28270511 |
66 | MP0001542_abnormal_bone_strength | 1.27824949 |
67 | MP0005165_increased_susceptibility_to | 1.25454184 |
68 | MP0005076_abnormal_cell_differentiation | 1.21670628 |
69 | MP0005174_abnormal_tail_pigmentation | 1.21198180 |
70 | MP0009785_altered_susceptibility_to | 1.16593877 |
71 | MP0003690_abnormal_glial_cell | 1.15712406 |
72 | MP0002138_abnormal_hepatobiliary_system | 1.15431706 |
73 | MP0000490_abnormal_crypts_of | 1.13286811 |
74 | MP0003566_abnormal_cell_adhesion | 1.11869423 |
75 | MP0002332_abnormal_exercise_endurance | 1.09553948 |
76 | MP0003329_amyloid_beta_deposits | 1.08596877 |
77 | MP0005310_abnormal_salivary_gland | 1.06278753 |
78 | MP0002148_abnormal_hypersensitivity_rea | 1.06275047 |
79 | MP0002254_reproductive_system_inflammat | 1.04124117 |
80 | MP0005164_abnormal_response_to | 1.03699083 |
81 | MP0003656_abnormal_erythrocyte_physiolo | 1.03065065 |
82 | MP0003448_altered_tumor_morphology | 1.01857841 |
83 | MP0010307_abnormal_tumor_latency | 1.00477762 |
84 | MP0002019_abnormal_tumor_incidence | 1.00187680 |
85 | MP0001853_heart_inflammation | 0.99044080 |
86 | MP0005257_abnormal_intraocular_pressure | 0.98734201 |
87 | MP0008874_decreased_physiological_sensi | 0.97096255 |
88 | MP0003279_aneurysm | 0.92932478 |
89 | MP0006082_CNS_inflammation | 0.92049940 |
90 | MP0001730_embryonic_growth_arrest | 0.90233071 |
91 | MP0003879_abnormal_hair_cell | 0.88277407 |
92 | MP0003191_abnormal_cellular_cholesterol | 0.86954233 |
93 | MP0003091_abnormal_cell_migration | 0.85447350 |
94 | MP0005666_abnormal_adipose_tissue | 0.84401226 |
95 | MP0000609_abnormal_liver_physiology | 0.82924800 |
96 | MP0008469_abnormal_protein_level | 0.82131067 |
97 | MP0005390_skeleton_phenotype | 0.81290308 |
98 | MP0003950_abnormal_plasma_membrane | 0.81014518 |
99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79080567 |
100 | MP0005375_adipose_tissue_phenotype | 0.77485711 |
101 | MP0009115_abnormal_fat_cell | 0.76348975 |
102 | MP0003705_abnormal_hypodermis_morpholog | 0.75828334 |
103 | MP0000249_abnormal_blood_vessel | 0.75042335 |
104 | MP0005595_abnormal_vascular_smooth | 0.75008496 |
105 | MP0005319_abnormal_enzyme/_coenzyme | 0.74786782 |
106 | MP0005360_urolithiasis | 0.74668844 |
107 | MP0000477_abnormal_intestine_morphology | 0.73323135 |
108 | MP0004130_abnormal_muscle_cell | 0.72637095 |
109 | MP0008770_decreased_survivor_rate | 0.72609840 |
110 | MP0005075_abnormal_melanosome_morpholog | 0.70347529 |
111 | MP0009763_increased_sensitivity_to | 0.70255839 |
112 | MP0010234_abnormal_vibrissa_follicle | 0.69754822 |
113 | MP0003186_abnormal_redox_activity | 0.68962111 |
114 | MP0005670_abnormal_white_adipose | 0.68920427 |
115 | MP0008057_abnormal_DNA_replication | 0.66952614 |
116 | MP0001533_abnormal_skeleton_physiology | 0.66910705 |
117 | MP0005647_abnormal_sex_gland | 0.66903132 |
118 | MP0001243_abnormal_dermal_layer | 0.66467402 |
119 | MP0003795_abnormal_bone_structure | 0.66301837 |
120 | MP0002877_abnormal_melanocyte_morpholog | 0.65314268 |
121 | MP0001764_abnormal_homeostasis | 0.65262854 |
122 | MP0002136_abnormal_kidney_physiology | 0.65133367 |
123 | MP0003077_abnormal_cell_cycle | 0.65012974 |
124 | MP0009643_abnormal_urine_homeostasis | 0.63603489 |
125 | MP0002132_abnormal_respiratory_system | 0.62571979 |
126 | MP0004019_abnormal_vitamin_homeostasis | 0.62358619 |
127 | MP0005535_abnormal_body_temperature | 0.62206995 |
128 | MP0000920_abnormal_myelination | 0.61429303 |
129 | MP0002970_abnormal_white_adipose | 0.61016033 |
130 | MP0001663_abnormal_digestive_system | 0.60980748 |
131 | MP0003453_abnormal_keratinocyte_physiol | 0.60532183 |
132 | MP0002089_abnormal_postnatal_growth/wei | 0.59959002 |
133 | MP0009765_abnormal_xenobiotic_induced | 0.59263062 |
134 | MP0004957_abnormal_blastocyst_morpholog | 0.57455483 |
135 | MP0000003_abnormal_adipose_tissue | 0.54409950 |
136 | MP0002086_abnormal_extraembryonic_tissu | 0.54400172 |
137 | MP0003787_abnormal_imprinting | 0.53113405 |
138 | MP0000350_abnormal_cell_proliferation | 0.53033355 |
139 | MP0003828_pulmonary_edema | 0.52025526 |
140 | MP0008873_increased_physiological_sensi | 0.48908616 |
141 | MP0009840_abnormal_foam_cell | 0.48030071 |
142 | MP0008877_abnormal_DNA_methylation | 0.47343503 |
143 | MP0002083_premature_death | 0.46069370 |
144 | MP0001784_abnormal_fluid_regulation | 0.45916400 |
145 | MP0000598_abnormal_liver_morphology | 0.45407867 |
146 | MP0000604_amyloidosis | 0.44926996 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 8.88100594 |
2 | Abnormality of T cell number (HP:0011839) | 8.32999349 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.78678887 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.78678887 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.78678887 |
6 | Systemic lupus erythematosus (HP:0002725) | 6.10345371 |
7 | Vacuolated lymphocytes (HP:0001922) | 5.84404341 |
8 | Abnormality of the fingertips (HP:0001211) | 5.39837605 |
9 | Abnormality of T cells (HP:0002843) | 5.27704014 |
10 | Disinhibition (HP:0000734) | 4.91696145 |
11 | Prolonged bleeding time (HP:0003010) | 4.89854845 |
12 | Dysostosis multiplex (HP:0000943) | 4.89390490 |
13 | Increased cerebral lipofuscin (HP:0011813) | 4.66435693 |
14 | Mutism (HP:0002300) | 4.58048023 |
15 | Pustule (HP:0200039) | 4.54658685 |
16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.51078049 |
17 | Combined immunodeficiency (HP:0005387) | 4.47275909 |
18 | Recurrent viral infections (HP:0004429) | 4.41939884 |
19 | Severe combined immunodeficiency (HP:0004430) | 4.37180741 |
20 | Loss of speech (HP:0002371) | 4.35121690 |
21 | Abnormal platelet volume (HP:0011876) | 4.19579026 |
22 | Nuclear cataract (HP:0100018) | 4.14821828 |
23 | Panhypogammaglobulinemia (HP:0003139) | 4.11455698 |
24 | Axonal loss (HP:0003447) | 4.09403500 |
25 | IgM deficiency (HP:0002850) | 4.03788914 |
26 | Abnormality of macrophages (HP:0004311) | 3.99961613 |
27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.98786219 |
28 | Glomerulonephritis (HP:0000099) | 3.96570782 |
29 | Autoimmune thrombocytopenia (HP:0001973) | 3.93284565 |
30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.76224074 |
31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.76224074 |
32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.76224074 |
33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.70424993 |
34 | Nasal polyposis (HP:0100582) | 3.68433423 |
35 | Increased mean platelet volume (HP:0011877) | 3.62999619 |
36 | Recurrent fungal infections (HP:0002841) | 3.59998926 |
37 | Mucopolysacchariduria (HP:0008155) | 3.53269650 |
38 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.53269650 |
39 | Neurofibrillary tangles (HP:0002185) | 3.40454610 |
40 | Complement deficiency (HP:0004431) | 3.39954005 |
41 | Spontaneous hematomas (HP:0007420) | 3.35419181 |
42 | Menorrhagia (HP:0000132) | 3.34312176 |
43 | Thyroiditis (HP:0100646) | 3.24180363 |
44 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.23758024 |
45 | Epistaxis (HP:0000421) | 3.14290367 |
46 | Basal cell carcinoma (HP:0002671) | 3.13766164 |
47 | Chronic otitis media (HP:0000389) | 3.10340352 |
48 | Abnormality of the nasal mucosa (HP:0000433) | 3.09276990 |
49 | Recurrent abscess formation (HP:0002722) | 3.06282120 |
50 | Amyloidosis (HP:0011034) | 3.06266112 |
51 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.05774993 |
52 | Recurrent bacterial skin infections (HP:0005406) | 3.02612470 |
53 | Abnormality of complement system (HP:0005339) | 2.99846593 |
54 | Hyperacusis (HP:0010780) | 2.96389428 |
55 | Recurrent bronchitis (HP:0002837) | 2.94776754 |
56 | Abnormality of eosinophils (HP:0001879) | 2.94469011 |
57 | Asymmetric septal hypertrophy (HP:0001670) | 2.89154755 |
58 | Apathy (HP:0000741) | 2.88722494 |
59 | Increased IgE level (HP:0003212) | 2.88253315 |
60 | Broad palm (HP:0001169) | 2.85801127 |
61 | Verrucae (HP:0200043) | 2.83388600 |
62 | Papilloma (HP:0012740) | 2.83388600 |
63 | Diminished motivation (HP:0000745) | 2.74678492 |
64 | Prolonged neonatal jaundice (HP:0006579) | 2.71656346 |
65 | Eosinophilia (HP:0001880) | 2.67924652 |
66 | Orchitis (HP:0100796) | 2.64719578 |
67 | Progressive neurologic deterioration (HP:0002344) | 2.62652392 |
68 | Joint swelling (HP:0001386) | 2.59025790 |
69 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.58050588 |
70 | Aortic aneurysm (HP:0004942) | 2.56182745 |
71 | Impaired platelet aggregation (HP:0003540) | 2.55251741 |
72 | Abnormal platelet function (HP:0011869) | 2.55251741 |
73 | Gastrointestinal inflammation (HP:0004386) | 2.54711474 |
74 | Upper motor neuron abnormality (HP:0002127) | 2.54397489 |
75 | Leukocytosis (HP:0001974) | 2.54189241 |
76 | Purpura (HP:0000979) | 2.52142568 |
77 | Inappropriate behavior (HP:0000719) | 2.50523333 |
78 | Inflammation of the large intestine (HP:0002037) | 2.50199785 |
79 | Thin bony cortex (HP:0002753) | 2.49992053 |
80 | Nephritis (HP:0000123) | 2.46645481 |
81 | Eczematoid dermatitis (HP:0000976) | 2.46292571 |
82 | Increased density of long bones (HP:0006392) | 2.45674363 |
83 | Personality changes (HP:0000751) | 2.45520916 |
84 | Malnutrition (HP:0004395) | 2.44813155 |
85 | Hypoplasia of the thymus (HP:0000778) | 2.44601092 |
86 | Cerebral inclusion bodies (HP:0100314) | 2.42285417 |
87 | Abnormality of oral frenula (HP:0000190) | 2.42284399 |
88 | Neuronal loss in central nervous system (HP:0002529) | 2.39602314 |
89 | Agnosia (HP:0010524) | 2.38832378 |
90 | Myositis (HP:0100614) | 2.38492650 |
91 | Abnormality of T cell physiology (HP:0011840) | 2.37894194 |
92 | Increased serum ferritin (HP:0003281) | 2.37131556 |
93 | Vertebral compression fractures (HP:0002953) | 2.35749098 |
94 | Granulocytopenia (HP:0001913) | 2.35354007 |
95 | Progressive hearing impairment (HP:0001730) | 2.34373352 |
96 | Metaphyseal irregularity (HP:0003025) | 2.33400033 |
97 | Lymphopenia (HP:0001888) | 2.30736955 |
98 | Hematochezia (HP:0002573) | 2.29253127 |
99 | Nausea (HP:0002018) | 2.27971662 |
100 | Seborrheic dermatitis (HP:0001051) | 2.27282497 |
101 | Bicuspid aortic valve (HP:0001647) | 2.27256494 |
102 | Retrobulbar optic neuritis (HP:0100654) | 2.26897999 |
103 | Optic neuritis (HP:0100653) | 2.26897999 |
104 | Dementia (HP:0000726) | 2.26637692 |
105 | Cardiomegaly (HP:0001640) | 2.26586149 |
106 | Macroorchidism (HP:0000053) | 2.26251632 |
107 | Gingivitis (HP:0000230) | 2.22898964 |
108 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.22776426 |
109 | Frequent falls (HP:0002359) | 2.22400818 |
110 | Myocardial infarction (HP:0001658) | 2.20501619 |
111 | IgG deficiency (HP:0004315) | 2.20227737 |
112 | Mediastinal lymphadenopathy (HP:0100721) | 2.19876488 |
113 | Hepatosplenomegaly (HP:0001433) | 2.19740321 |
114 | Peripheral demyelination (HP:0011096) | 2.17356459 |
115 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.15618463 |
116 | Ureteral stenosis (HP:0000071) | 2.12785324 |
117 | Gingival bleeding (HP:0000225) | 2.09318428 |
118 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06187578 |
119 | Obstructive lung disease (HP:0006536) | 2.06107348 |
120 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06107348 |
121 | Conjunctival telangiectasia (HP:0000524) | 2.05439440 |
122 | Narrow palate (HP:0000189) | 2.02456830 |
123 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.01658345 |
124 | Recurrent cutaneous fungal infections (HP:0011370) | 2.01658345 |
125 | Subcapsular cataract (HP:0000523) | 2.01325416 |
126 | Broad metatarsal (HP:0001783) | 1.98708032 |
127 | Premature skin wrinkling (HP:0100678) | 1.97423166 |
128 | Bone pain (HP:0002653) | 1.96756443 |
129 | Meningitis (HP:0001287) | 1.96433527 |
130 | Polyneuropathy (HP:0001271) | 1.94428833 |
131 | Pathologic fracture (HP:0002756) | 1.94050630 |
132 | Interstitial pulmonary disease (HP:0006530) | 1.93002224 |
133 | Stomatitis (HP:0010280) | 1.92639772 |
134 | Basal ganglia calcification (HP:0002135) | 1.92629610 |
135 | Supranuclear gaze palsy (HP:0000605) | 1.91599128 |
136 | Chronic diarrhea (HP:0002028) | 1.90823230 |
137 | Persistence of primary teeth (HP:0006335) | 1.89584841 |
138 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.87266118 |
139 | Skin tags (HP:0010609) | 1.87219702 |
140 | Anal stenosis (HP:0002025) | 1.86492303 |
141 | Thrombocytosis (HP:0001894) | 1.86343171 |
142 | Pulmonary embolism (HP:0002204) | 1.85933875 |
143 | Tetraparesis (HP:0002273) | 1.84534580 |
144 | Pulmonary infiltrates (HP:0002113) | 1.84311871 |
145 | Zonular cataract (HP:0010920) | 1.83669364 |
146 | Ureteral obstruction (HP:0006000) | 1.83365376 |
147 | Abnormal number of erythroid precursors (HP:0012131) | 1.82572581 |
148 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.82474903 |
149 | Retinal atrophy (HP:0001105) | 1.81575431 |
150 | Hypertensive crisis (HP:0100735) | 1.81558282 |
151 | Spinal canal stenosis (HP:0003416) | 1.80401076 |
152 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.80089373 |
153 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.79708140 |
154 | Hypokinesia (HP:0002375) | 1.79549664 |
155 | Abnormality of iron homeostasis (HP:0011031) | 1.79392827 |
156 | Prominent nose (HP:0000448) | 1.77712588 |
157 | Hypochromic anemia (HP:0001931) | 1.76999513 |
158 | Hypoalphalipoproteinemia (HP:0003233) | 1.76497443 |
159 | High pitched voice (HP:0001620) | 1.75708331 |
160 | Cerebral aneurysm (HP:0004944) | 1.75268579 |
161 | Urinary urgency (HP:0000012) | 1.74769929 |
162 | Mitral regurgitation (HP:0001653) | 1.73830799 |
163 | Hydroxyprolinuria (HP:0003080) | 1.73324322 |
164 | Abnormality of proline metabolism (HP:0010907) | 1.73324322 |
165 | Beaking of vertebral bodies (HP:0004568) | 1.73058072 |
166 | Thoracolumbar scoliosis (HP:0002944) | 1.72282260 |
167 | Heterotopia (HP:0002282) | 1.71452052 |
168 | Sparse lateral eyebrow (HP:0005338) | 1.71296986 |
169 | Vertebral arch anomaly (HP:0008438) | 1.70903205 |
170 | Abnormality of lateral ventricle (HP:0030047) | 1.69836824 |
171 | Abnormality of the basal ganglia (HP:0002134) | 1.69163445 |
172 | Depressed nasal tip (HP:0000437) | 1.67590588 |
173 | Autoimmune hemolytic anemia (HP:0001890) | 1.66976287 |
174 | Encephalitis (HP:0002383) | 1.66568346 |
175 | Pseudobulbar signs (HP:0002200) | 1.65973477 |
176 | Mucosal telangiectasiae (HP:0100579) | 1.65626117 |
177 | Lymphoma (HP:0002665) | 1.65331605 |
178 | Increased CSF protein (HP:0002922) | 1.63544810 |
179 | Protuberant abdomen (HP:0001538) | 1.63349782 |
180 | Microcytic anemia (HP:0001935) | 1.63240314 |
181 | Dilatation of the ascending aorta (HP:0005111) | 1.63075142 |
182 | Generalized aminoaciduria (HP:0002909) | 1.62739767 |
183 | Petechiae (HP:0000967) | 1.62353065 |
184 | Recurrent otitis media (HP:0000403) | 1.61951245 |
185 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.60984867 |
186 | Striae distensae (HP:0001065) | 1.60626224 |
187 | B lymphocytopenia (HP:0010976) | 1.60402216 |
188 | Global brain atrophy (HP:0002283) | 1.60158386 |
189 | Severe visual impairment (HP:0001141) | 1.60073224 |
190 | Bone cyst (HP:0012062) | 1.59176686 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.49896871 |
2 | IRAK3 | 4.47756186 |
3 | EEF2K | 4.30368165 |
4 | TXK | 4.01014125 |
5 | MAP3K10 | 3.57955242 |
6 | STK10 | 3.45417559 |
7 | DDR2 | 3.27385200 |
8 | GRK6 | 2.99808880 |
9 | RIPK1 | 2.94211838 |
10 | GRK7 | 2.73085676 |
11 | MST1R | 2.65388882 |
12 | ITK | 2.59337561 |
13 | TAOK2 | 2.57038155 |
14 | ERN1 | 2.50561566 |
15 | MAP3K3 | 2.48254762 |
16 | ACVR1B | 2.39415095 |
17 | JAK3 | 2.37847739 |
18 | PIM2 | 2.35116427 |
19 | SIK2 | 2.29830837 |
20 | MAP3K11 | 2.19691073 |
21 | ARAF | 2.16447162 |
22 | MOS | 2.15046674 |
23 | ZAP70 | 2.11678287 |
24 | TRPM7 | 2.05666298 |
25 | PKN2 | 1.93581839 |
26 | MAP3K7 | 1.91785726 |
27 | ABL2 | 1.88663116 |
28 | MAP3K13 | 1.86082647 |
29 | FGFR4 | 1.83933734 |
30 | MARK3 | 1.71973018 |
31 | PRKCH | 1.69695068 |
32 | CSK | 1.68103612 |
33 | TRIB3 | 1.61351204 |
34 | MATK | 1.59540201 |
35 | TYK2 | 1.56617786 |
36 | TNK2 | 1.56291461 |
37 | TESK2 | 1.53928564 |
38 | LRRK2 | 1.53061179 |
39 | FGFR3 | 1.49033648 |
40 | EPHB1 | 1.48880088 |
41 | LCK | 1.39931339 |
42 | FGFR2 | 1.36580071 |
43 | MARK2 | 1.36229397 |
44 | MAP3K1 | 1.35996325 |
45 | TTN | 1.34228511 |
46 | MST4 | 1.31091800 |
47 | CLK1 | 1.29197767 |
48 | ALK | 1.28990117 |
49 | PRPF4B | 1.28840717 |
50 | RIPK4 | 1.28831437 |
51 | SYK | 1.28664148 |
52 | PAK4 | 1.27478580 |
53 | FES | 1.25218011 |
54 | BTK | 1.23168236 |
55 | TYRO3 | 1.22573644 |
56 | HCK | 1.22065956 |
57 | MAP2K3 | 1.19217042 |
58 | EPHB2 | 1.17137814 |
59 | PLK4 | 1.15394753 |
60 | CAMKK2 | 1.14677665 |
61 | CDC42BPA | 1.14041131 |
62 | FGR | 1.12748834 |
63 | RPS6KB2 | 1.09413225 |
64 | EPHA2 | 1.09179169 |
65 | CDK12 | 1.08142543 |
66 | KDR | 1.07048787 |
67 | MAP3K14 | 1.05239662 |
68 | PTK6 | 0.99791143 |
69 | PIM1 | 0.97854252 |
70 | CDK4 | 0.96450556 |
71 | IRAK4 | 0.95306354 |
72 | JAK2 | 0.93880231 |
73 | PRKCQ | 0.93449656 |
74 | IKBKE | 0.91688141 |
75 | BLK | 0.90133647 |
76 | TAOK1 | 0.89294051 |
77 | PRKD2 | 0.88788794 |
78 | NLK | 0.86249905 |
79 | PRKG2 | 0.85218843 |
80 | PDGFRB | 0.84879311 |
81 | HIPK2 | 0.84441638 |
82 | CHUK | 0.79194296 |
83 | JAK1 | 0.78798136 |
84 | PDK1 | 0.77565923 |
85 | BRAF | 0.76913261 |
86 | MAP3K12 | 0.76321957 |
87 | LATS2 | 0.76311547 |
88 | SIK1 | 0.74733646 |
89 | ADRBK2 | 0.73492376 |
90 | CAMK1D | 0.71397822 |
91 | BMPR2 | 0.70533848 |
92 | MAP3K5 | 0.66415444 |
93 | TEC | 0.66250828 |
94 | PDPK1 | 0.66062118 |
95 | STK11 | 0.65068673 |
96 | PBK | 0.63304207 |
97 | MAP2K6 | 0.60001375 |
98 | MET | 0.57318841 |
99 | NME2 | 0.57241899 |
100 | NEK2 | 0.55828586 |
101 | DMPK | 0.53744394 |
102 | ICK | 0.51280819 |
103 | MAP3K9 | 0.49722900 |
104 | STK4 | 0.49596409 |
105 | MYLK | 0.49199755 |
106 | PDGFRA | 0.48659567 |
107 | FYN | 0.47517537 |
108 | MAPK4 | 0.47264667 |
109 | NTRK2 | 0.47223383 |
110 | CSF1R | 0.46800442 |
111 | LYN | 0.46221241 |
112 | TAOK3 | 0.46107597 |
113 | INSRR | 0.45719930 |
114 | PRKD1 | 0.45178877 |
115 | TBK1 | 0.43717604 |
116 | TGFBR2 | 0.42362079 |
117 | MAPK12 | 0.42320089 |
118 | LIMK1 | 0.42095681 |
119 | RET | 0.41747582 |
120 | KSR2 | 0.41255301 |
121 | MELK | 0.41254867 |
122 | CDK6 | 0.40461803 |
123 | TGFBR1 | 0.39502232 |
124 | CDK19 | 0.38127331 |
125 | FGFR1 | 0.37310840 |
126 | SRC | 0.37012942 |
127 | BMX | 0.36864359 |
128 | DAPK3 | 0.35648271 |
129 | MAP3K8 | 0.35597293 |
130 | TESK1 | 0.34765423 |
131 | PASK | 0.32724741 |
132 | CDC7 | 0.32263174 |
133 | UHMK1 | 0.32035996 |
134 | SIK3 | 0.31615820 |
135 | SCYL2 | 0.30971209 |
136 | ABL1 | 0.29385547 |
137 | INSR | 0.29293721 |
138 | PAK1 | 0.28889351 |
139 | LMTK2 | 0.28510642 |
140 | PRKAA2 | 0.28070664 |
141 | MTOR | 0.27553358 |
142 | DYRK1B | 0.26830576 |
143 | MAPKAPK2 | 0.25294337 |
144 | RPS6KA4 | 0.24251964 |
145 | IKBKB | 0.23264267 |
146 | MAPK9 | 0.22851799 |
147 | MAPK7 | 0.22750679 |
148 | CAMK1G | 0.22680684 |
149 | PRKCB | 0.21987122 |
150 | RPS6KA6 | 0.21444788 |
151 | CAMK2G | 0.21076660 |
152 | ROCK2 | 0.20886952 |
153 | MAPK11 | 0.20309774 |
154 | RPS6KC1 | 0.20262113 |
155 | STK38 | 0.19402804 |
156 | DAPK1 | 0.17808396 |
157 | IRAK2 | 0.15953754 |
158 | CDK14 | 0.15184708 |
159 | EGFR | 0.15069299 |
160 | BCKDK | 0.14667422 |
161 | NEK9 | 0.12605872 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.25297478 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 4.75221424 |
3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.33387062 |
4 | Lysosome_Homo sapiens_hsa04142 | 3.48134508 |
5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.30624291 |
6 | Asthma_Homo sapiens_hsa05310 | 2.68476621 |
7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.55663511 |
8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.49583092 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 2.48406793 |
10 | Measles_Homo sapiens_hsa05162 | 2.20095551 |
11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.19203815 |
12 | Pertussis_Homo sapiens_hsa05133 | 2.12920724 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.10147134 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.03072193 |
15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.02649527 |
16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.01627463 |
17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.98612748 |
18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95122466 |
19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94674904 |
20 | Tuberculosis_Homo sapiens_hsa05152 | 1.93472582 |
21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.88418576 |
22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86861328 |
23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.85594957 |
24 | Platelet activation_Homo sapiens_hsa04611 | 1.77664659 |
25 | Phagosome_Homo sapiens_hsa04145 | 1.75254332 |
26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73119855 |
27 | Legionellosis_Homo sapiens_hsa05134 | 1.69742489 |
28 | Malaria_Homo sapiens_hsa05144 | 1.67881892 |
29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.64856695 |
30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63934315 |
31 | Mineral absorption_Homo sapiens_hsa04978 | 1.62818257 |
32 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.61073908 |
33 | Ribosome_Homo sapiens_hsa03010 | 1.59284445 |
34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.57236796 |
35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52830966 |
36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52822173 |
37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.48570167 |
38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.48166165 |
39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44847107 |
40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42978411 |
41 | Colorectal cancer_Homo sapiens_hsa05210 | 1.41317237 |
42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.40854273 |
43 | Prion diseases_Homo sapiens_hsa05020 | 1.39870795 |
44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.35761405 |
45 | HTLV-I infection_Homo sapiens_hsa05166 | 1.31260395 |
46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.29867461 |
47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.27677747 |
48 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.24099394 |
49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.23415830 |
50 | Lysine degradation_Homo sapiens_hsa00310 | 1.21579459 |
51 | Hepatitis B_Homo sapiens_hsa05161 | 1.20420087 |
52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18729739 |
53 | Galactose metabolism_Homo sapiens_hsa00052 | 1.16259127 |
54 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15416968 |
55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14659489 |
56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.13202197 |
57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12098189 |
58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09803618 |
59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09261278 |
60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06721198 |
61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.04218712 |
62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03295147 |
63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01842910 |
64 | Shigellosis_Homo sapiens_hsa05131 | 0.96760126 |
65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95596958 |
66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95218982 |
67 | Spliceosome_Homo sapiens_hsa03040 | 0.94422489 |
68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93755142 |
69 | Bladder cancer_Homo sapiens_hsa05219 | 0.93074602 |
70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93059373 |
71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91536210 |
72 | Long-term potentiation_Homo sapiens_hsa04720 | 0.91146472 |
73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90728935 |
74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89807856 |
75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89624682 |
76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88045434 |
77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85832300 |
78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85045781 |
79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84803193 |
80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.83690959 |
81 | Insulin resistance_Homo sapiens_hsa04931 | 0.83473945 |
82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.82889421 |
83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82009832 |
84 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79007701 |
85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78119466 |
86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76885791 |
87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76266401 |
88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76140780 |
89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76076337 |
90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75561393 |
91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75011081 |
92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74811297 |
93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73708835 |
94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73318935 |
95 | Apoptosis_Homo sapiens_hsa04210 | 0.72530866 |
96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71409132 |
97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70956973 |
98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70890747 |
99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70316496 |
100 | Salmonella infection_Homo sapiens_hsa05132 | 0.68384379 |
101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68130145 |
102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67688173 |
103 | Glioma_Homo sapiens_hsa05214 | 0.67514295 |
104 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66768239 |
105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66638333 |
106 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.64168421 |
107 | Amoebiasis_Homo sapiens_hsa05146 | 0.64051404 |
108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62861813 |
109 | Influenza A_Homo sapiens_hsa05164 | 0.62566019 |
110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59620070 |
111 | Endocytosis_Homo sapiens_hsa04144 | 0.59298407 |
112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59159145 |
113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59004368 |
114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58196388 |
115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58032436 |
116 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56646195 |
117 | Hepatitis C_Homo sapiens_hsa05160 | 0.55186658 |
118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55041748 |
119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54731220 |
120 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.54634014 |
121 | Focal adhesion_Homo sapiens_hsa04510 | 0.54444599 |
122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54217206 |
123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53521490 |
124 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53375930 |
125 | DNA replication_Homo sapiens_hsa03030 | 0.52717601 |
126 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51535616 |
127 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50653026 |
128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50605382 |
129 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50153776 |
130 | Prostate cancer_Homo sapiens_hsa05215 | 0.48274902 |
131 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47637387 |
132 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45913960 |
133 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45412735 |
134 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.45118054 |
135 | Pathways in cancer_Homo sapiens_hsa05200 | 0.44925801 |
136 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43000296 |
137 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42964490 |
138 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42657335 |
139 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42549279 |
140 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41876964 |
141 | Renin secretion_Homo sapiens_hsa04924 | 0.41374133 |
142 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41135973 |
143 | Morphine addiction_Homo sapiens_hsa05032 | 0.39543278 |
144 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38913509 |
145 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38896275 |
146 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37704094 |
147 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37534448 |
148 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35807964 |
149 | Proteasome_Homo sapiens_hsa03050 | 0.29833345 |
150 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28992899 |
151 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27801742 |
152 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.23884787 |
153 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.23841644 |
154 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23612057 |
155 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.21267904 |
156 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19661070 |
157 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18318315 |
158 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.14826147 |